FDA Inspection
EirGen Pharma LtdEirGen Pharma Ltd – FDA Inspection, Feb 9, 2018
Record Details
This FDA Inspection record concerns EirGen Pharma Ltd, with an inspection on February 9, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 38df6883-00ec-43b2-9c16-2cdf1cedbe90
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1044406
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of EirGen Pharma Ltd
6| Date | Classification | Office | Project area |
|---|---|---|---|
| October 13, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 27, 2023 | Not classified | Office of Inspections and Investigations | |
| March 3, 2017 | Not classified | Office of Inspections and Investigations | |
| August 15, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 14, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for EirGen Pharma Ltd
- FDA Inspection 1276330 - 2023-10-13
- FDA Inspection 1199821 - 2023-01-27
- FDA Inspection 1009392 - 2017-03-03
- FDA Inspection 892754 - 2014-08-15
- FDA Inspection 803013 - 2012-09-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.